CV Sciences, Inc. (CVSI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 25M 50M 75M Q4 '12: 0 Q1 '13: 1.1M Q2 '13: 1.2M Q3 '13: 1.4M Q4 '13: 2.2M Q1 '14: 3.7M Q2 '14: 6.6M Q3 '14: 8.3M Q4 '14: 10.2M Q1 '15: 10.3M Q2 '15: 9.7M Q3 '15: 12M Q4 '15: 11.5M Q1 '16: 11.2M Q2 '16: 11.3M Q3 '16: 10.1M Q4 '16: 11.1M Q1 '17: 12.4M Q2 '17: 14M Q3 '17: 16.6M Q4 '17: 20.7M Q1 '18: 25M Q2 '18: 33.3M Q3 '18: 41.3M Q4 '18: 48.2M Q1 '19: 55.1M Q2 '19: 59.6M Q3 '19: 58.6M Q4 '19: 53.7M Q1 '20: 47.1M Q2 '20: 35.6M Q3 '20: 28.6M Q4 '20: 24.4M Q1 '21: 21M Q2 '21: 20.7M Q3 '21: 20.3M Q4 '21: 20M Q1 '22: 19.7M Q2 '22: 18.7M Q3 '22: 17.3M Q4 '22: 16.2M Q1 '23: 15.9M Q2 '23: 15.7M Q3 '23: 16.1M Q4 '23: 16M Q1 '24: 15.9M Q2 '24: 15.8M Q3 '24: 15.6M Q4 '24: 15.7M Q1 '25: 15.3M Q2 '25: 15M Q3 '25: 14.4M Q4 '25: 13.8M Q1 '26: 13.4M Q2 '26: 12.7M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Gross Profit TTM

0 15M 30M 45M Q4 '12: 0 Q1 '13: 876.9K Q2 '13: 968.3K Q3 '13: 1.1M Q4 '13: 1.3M Q1 '14: 2M Q2 '14: 3.7M Q3 '14: 4.7M Q4 '14: 5.8M Q1 '15: 5.8M Q2 '15: 5.3M Q3 '15: 6.6M Q4 '15: 6.7M Q1 '16: 6.7M Q2 '16: 7.1M Q3 '16: 6.5M Q4 '16: 7M Q1 '17: 7.8M Q2 '17: 9M Q3 '17: 11.1M Q4 '17: 14.5M Q1 '18: 17.6M Q2 '18: 23.8M Q3 '18: 29.8M Q4 '18: 33.9M Q1 '19: 38.9M Q2 '19: 41.8M Q3 '19: 40.2M Q4 '19: 35.1M Q1 '20: 28.5M Q2 '20: 18.9M Q3 '20: 12.9M Q4 '20: 11M Q1 '21: 9.4M Q2 '21: 9.3M Q3 '21: 9.2M Q4 '21: 8.6M Q1 '22: 7.4M Q2 '22: 6.4M Q3 '22: 5.6M Q4 '22: 5.5M Q1 '23: 6.2M Q2 '23: 6.6M Q3 '23: 6.9M Q4 '23: 7.1M Q1 '24: 7.2M Q2 '24: 7.3M Q3 '24: 7.2M Q4 '24: 7.2M Q1 '25: 7M Q2 '25: 7M Q3 '25: 6.8M Q4 '25: 6.8M Q1 '26: 6.7M Q2 '26: 6.3M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating Income TTM

-24M -16M -8M 0 8M 16M 24M Q4 '12: -43K Q1 '13: 655.6K Q2 '13: 339.3K Q3 '13: -328.1K Q4 '13: -1.6M Q1 '14: -1.8M Q2 '14: -1.3M Q3 '14: -1.1M Q4 '14: -8.6M Q1 '15: -11.8M Q2 '15: -13.9M Q3 '15: -14.3M Q4 '15: -11.2M Q1 '16: -9.7M Q2 '16: -9.8M Q3 '16: -10.5M Q4 '16: -13.1M Q1 '17: -15.5M Q2 '17: -14.3M Q3 '17: -13.2M Q4 '17: -4.9M Q1 '18: -538.2K Q2 '18: 3.6M Q3 '18: 7.6M Q4 '18: 10.2M Q1 '19: 202K Q2 '19: -1.8M Q3 '19: -7.1M Q4 '19: -17.2M Q1 '20: -13.2M Q2 '20: -19.1M Q3 '20: -20.5M Q4 '20: -22.6M Q1 '21: -20.4M Q2 '21: -19.2M Q3 '21: -19.1M Q4 '21: -18.4M Q1 '22: -16.8M Q2 '22: -15.7M Q3 '22: -13.6M Q4 '22: -6.8M Q1 '23: 430K Q2 '23: 1.7M Q3 '23: 2.1M Q4 '23: 3.4M Q1 '24: -3M Q2 '24: -2.5M Q3 '24: -2.4M Q4 '24: -2.2M Q1 '25: -1.6M Q2 '25: -1.1M Q3 '25: -1M Q4 '25: -470K Q1 '26: -799K Q2 '26: -969K Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Net Income TTM

-24M -16M -8M 0 8M 16M 24M Q4 '11: -90.2K Q1 '12: -67.6K Q2 '12: -58.5K Q3 '12: -50.8K Q4 '12: -45.6K Q1 '13: 653.8K Q2 '13: 318K Q3 '13: -482.9K Q4 '13: -2.3M Q1 '14: -3.1M Q2 '14: 5.3M Q3 '14: 5.6M Q4 '15: -12.2M Q1 '16: -11.1M Q2 '16: -11.3M Q3 '16: -12.3M Q4 '16: -14.1M Q1 '17: -16.4M Q2 '17: -15.2M Q3 '17: -13.8M Q4 '17: -4.9M Q1 '18: -493.2K Q2 '18: 3.7M Q3 '18: 7.6M Q4 '18: 10M Q1 '19: -2K Q2 '19: -2M Q3 '19: -7M Q4 '19: -16.6M Q1 '20: -12.4M Q2 '20: -18.3M Q3 '20: -19.7M Q4 '20: -22.3M Q1 '21: -20.3M Q2 '21: -19.1M Q3 '21: -16M Q4 '21: -15.6M Q1 '22: -14.6M Q2 '22: -13.8M Q3 '22: -14.8M Q4 '22: -8.2M Q1 '23: -291K Q2 '23: 1.1M Q3 '23: 1.7M Q4 '23: 3.1M Q1 '24: -3.2M Q2 '24: -2.5M Q3 '24: -2.5M Q4 '24: -2.4M Q1 '25: -1.9M Q2 '25: -1.6M Q3 '25: -1.5M Q4 '25: -958K Q1 '26: -1.5M Q2 '26: -2M Q1 '13 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue TTM

0 7M 14M 21M Q4 '12: 0 Q1 '13: 205.4K Q2 '13: 221.7K Q3 '13: 270.3K Q4 '13: 880.5K Q1 '14: 1.7M Q2 '14: 2.9M Q3 '14: 3.6M Q4 '14: 4.4M Q1 '15: 4.5M Q2 '15: 4.4M Q3 '15: 5.4M Q4 '15: 4.8M Q1 '16: 4.5M Q2 '16: 4.2M Q3 '16: 3.6M Q4 '16: 4.1M Q1 '17: 4.6M Q2 '17: 5M Q3 '17: 5.6M Q4 '17: 6.2M Q1 '18: 7.4M Q2 '18: 9.4M Q3 '18: 11.5M Q4 '18: 14.4M Q1 '19: 16.2M Q2 '19: 17.8M Q3 '19: 18.3M Q4 '19: 18.6M Q1 '20: 18.5M Q2 '20: 16.7M Q3 '20: 15.6M Q4 '20: 13.4M Q1 '21: 11.6M Q2 '21: 11.4M Q3 '21: 11.1M Q4 '21: 11.4M Q1 '22: 12.2M Q2 '22: 12.3M Q3 '22: 11.7M Q4 '22: 10.7M Q1 '23: 9.7M Q2 '23: 9.1M Q3 '23: 9.2M Q4 '23: 8.9M Q1 '24: 8.7M Q2 '24: 8.5M Q3 '24: 8.4M Q4 '24: 8.5M Q1 '25: 8.3M Q2 '25: 8M Q3 '25: 7.6M Q4 '25: 7M Q1 '26: 6.7M Q2 '26: 6.5M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating Cash Flow TTM

-10M -5M 0 5M 10M 15M Q4 '11: -79.6K Q1 '12: -50.4K Q2 '12: -44.3K Q3 '12: -51.2K Q4 '12: -64.1K Q1 '13: -738.7K Q2 '13: -2M Q3 '13: -2.9M Q4 '13: -4.9M Q1 '14: -5.1M Q2 '14: -3.9M Q3 '14: -7.4M Q4 '14: -6.7M Q1 '15: -8.4M Q2 '15: -9.5M Q3 '15: -4.2M Q4 '15: -4.2M Q1 '16: -1.7M Q2 '16: -1.3M Q3 '16: -2.7M Q4 '16: -2.1M Q1 '17: -1.9M Q2 '17: -943.8K Q3 '17: 22.8K Q4 '17: 3.6M Q1 '18: 5.2M Q2 '18: 8.8M Q3 '18: 12.9M Q4 '18: 12.6M Q1 '19: 11.7M Q2 '19: 10.6M Q3 '19: 5M Q4 '20: -7.3M Q1 '21: -7.3M Q2 '21: -7.9M Q3 '21: -7.8M Q4 '21: -7.5M Q1 '22: -6.2M Q2 '22: -4.3M Q3 '22: -3.3M Q4 '22: -1.9M Q1 '23: -531K Q2 '23: 2M Q3 '23: 2.6M Q4 '23: 2.3M Q1 '24: 760K Q2 '24: -708K Q3 '24: -811K Q4 '24: -861K Q1 '25: -424K Q2 '25: -80K Q3 '25: -217K Q4 '25: -407K Q1 '26: -225K Q2 '26: -492K Q1 '13 Q4 '14 Q3 '16 Q2 '18 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Free Cash Flow TTM

-10M -5M 0 5M 10M 15M Q3 '13: -3.1M Q4 '13: -5.1M Q1 '14: -5.3M Q2 '14: -4.3M Q3 '14: -7.8M Q4 '14: -7.2M Q1 '15: -8.9M Q2 '15: -9.8M Q3 '15: -4.4M Q4 '15: -4.3M Q1 '16: -1.8M Q2 '16: -1.3M Q3 '16: -2.8M Q4 '16: -2.1M Q1 '17: -1.9M Q2 '17: -967.4K Q3 '17: 16.3K Q4 '17: 3.2M Q1 '18: 4.7M Q2 '18: 8.1M Q3 '18: 12.1M Q4 '18: 11.7M Q1 '19: 10.9M Q2 '19: 9.4M Q3 '19: 3.6M Q4 '20: -8.4M Q1 '21: -7.9M Q2 '21: -8.5M Q3 '21: -8.1M Q4 '21: -7.5M Q1 '22: -6.2M Q2 '22: -4.3M Q3 '22: -3.3M Q4 '22: -1.9M Q4 '24: -879K Q1 '25: -482K Q2 '25: -187K Q3 '25: -335K Q4 '25: -516K Q1 '26: -297K Q2 '26: -522K Q3 '14 Q1 '16 Q3 '17 Q1 '19 Q3 '21 Q4 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '11: 6.9M Q2 '11: 7M Q3 '11: 7M Q1 '12: 7M Q2 '12: 7M Q3 '12: 7M Q1 '17: 60.1M Q2 '17: 82.9M Q3 '17: 88.1M Q1 '18: 95.6M Q2 '18: 112.5M Q3 '18: 115.9M Q1 '19: 95.2M Q2 '19: 120.9M Q3 '19: 98.7M Q2 '20: 99.9M Q3 '20: 100M Q1 '21: 104.5M Q2 '21: 107.6M Q3 '21: 109.1M Q1 '22: 116.8M Q2 '22: 135.4M Q3 '22: 146.5M Q1 '23: 152.1M Q2 '23: 152.6M Q3 '23: 154.6M Q1 '24: 163.1M Q2 '24: 172.4M Q3 '24: 182.3M Q1 '25: 184.3M Q2 '25: 184.3M Q3 '25: 184.3M Q1 '26: 186.9M Q2 '26: 205.1M Q1 '12 Q3 '17 Q2 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q4 '11: -0.01 Q1 '12: 0.00 Q2 '12: 0.00 Q3 '12: 0.00 Q4 '12: 0.00 Q1 '13: 0.09 Q2 '13: 0.05 Q3 '13: -0.03 Q4 '13: -0.21 Q1 '14: -0.30 Q2 '14: -0.02 Q3 '14: 0.05 Q4 '15: -0.36 Q1 '16: -0.31 Q2 '16: -0.29 Q3 '16: -0.30 Q4 '16: -0.27 Q1 '17: -0.30 Q2 '17: -0.27 Q3 '17: -0.24 Q4 '17: -0.06 Q1 '18: 0.01 Q2 '18: 0.05 Q3 '18: 0.09 Q4 '18: 0.10 Q1 '19: -0.01 Q2 '19: -0.03 Q3 '19: -0.08 Q4 '19: -0.18 Q1 '20: -0.13 Q2 '20: -0.19 Q3 '20: -0.20 Q4 '20: -0.22 Q1 '21: -0.20 Q2 '21: -0.18 Q3 '21: -0.15 Q4 '21: -0.14 Q1 '22: -0.13 Q2 '22: -0.13 Q3 '22: -0.14 Q4 '22: -0.08 Q1 '23: -0.02 Q2 '23: -0.00 Q3 '23: 0.01 Q4 '23: 0.02 Q1 '24: -0.02 Q2 '24: -0.01 Q3 '24: -0.01 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: -0.01 Q1 '26: -0.01 Q2 '26: -0.01 Q1 '13 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.